"10.1371_journal.pone.0039909","plos one","2012-06-29T00:00:00Z","Rolf Billeskov; Tara T Elvang; Peter L Andersen; Jes Dietrich","Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark","Conceived and designed the experiments: RB JD PA. Performed the experiments: RB JD TE. Analyzed the data: RB JD. Wrote the paper: RB JD.","PA and JD are co-inventors of patents relating to tuberculosis fusion protein vaccine Ag85B-TB10.4 (H4). All rights have been assigned to the Statens Serum Institut. Statens Serum Institut is involved in the development of the H4-IC31Â® vaccine currently in clinical trials in partnership with Sanofi Pasteur. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","06","Rolf Billeskov","RB",4,TRUE,3,3,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
